Archive for the ‘Esomeprazole’ tag
Nexium – 50 states
50 states. 1 healing purple pill a day.
The majority of patients with prescription drug coverage for Nexium pay $30 or less per month
Brand name: Nexium
Generic name/category: esomeprazole, Proton pump inhibitors (PPI)
Company: AstraZeneca
Country/Market: USA, North America
Indication(s)/use: prevent the formation of gastric acid
Target: Direct to consumer (DTC)
Medium: Print ad
Size/duration: Single-page
Publication/Aired: Reader's Digest – February 2009
To see all of this brand's ads on AdPharm, click here
From Wikipedia:
Esomeprazole is a proton pump inhibitor (brand names Sompraz, Zoleri, Nexium??, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole (marketed as Losec/Prilosec), and AstraZeneca claims improved efficacy of this single enantiomer product over the racemic mixture of omeprazole. However, this greater efficacy has been disputed, with some claiming it offers no benefit from its older form.
Click here to see the details and full-size version of this ad on AdPharm
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Nexium DTC US print ad
What heals me?
A beautiful afternoon. Time with friends.
And, for acid reflux damage, my nexium.
Ask your doctor about Nexium, the healing purple pill.
Visit www.purplepill.com/heal or call 1-877-56-NEXIUM
Esomeprazole Esomeprazole (pronounced /?so??m?pr?zo?l/) is a proton pump inhibitor (brand names Sompraz, Zoleri, Nexium, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole (marketed as Losec/Prilosec), and AstraZeneca claims improved efficacy of this single enantiomer product over the racemic mixture of omeprazole. However, this greater efficacy has been disputed, with some claiming it offers no benefit from its older form. (see below). Esomeprazole was the third biggest selling pharmaceutical drug in the world for 2005, totaling US$ 5.7 billion in sales.
Brand name: Nexium
Generic name/category: Esomeprazole
Company: AstraZeneca
Country/Market: USA
Indication(s)/use: reduction of gastric acid, reflux esophagitis, heartburn, etc
Target: Consumers (DTC)
Tagline: The healing purple pill
Publication: Reader’s Digest June 2009
More Nexium ads on AdPharm
Nexium ad for Canadian HCPs
Thank you doctor!
See what can happen. Nexium
Esomeprazole Esomeprazole is a proton pump inhibitor (brand names Sompraz, Zoleri, Nexium, Lucen, Esopral; Axagon in Italy, Nexiam in Belgium) developed and marketed by AstraZeneca which is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. Esomeprazole is the S-enantiomer of omeprazole (marketed as Losec/Prilosec), and AstraZeneca claims improved efficacy of this single enantiomer product over the racemic mixture of omeprazole. However, this greater efficacy has been disputed, with some claiming it offers no benefit from its older form. (see below). Esomeprazole was the third biggest selling pharmaceutical drug in the world for 2005, totaling US$ 5.7 billion in sales.
Brand name: Nexium
Generic name/category: Esomeprazole
Company: AstraZeneca
Country/Market: Canada
Indication(s)/use: reduction of gastric acid, reflux esophagitis, heartburn, etc
Target: Healthcare Professionals (HCP)
Tagline: See what can happen
Publication: The Journal of Gastroenterology May 2009
